2013
DOI: 10.1128/aac.01096-13
|View full text |Cite
|
Sign up to set email alerts
|

Association of Higher Plasma Vitamin D Binding Protein and Lower Free Calcitriol Levels with Tenofovir Disoproxil Fumarate Use and Plasma and Intracellular Tenofovir Pharmacokinetics: Cause of a Functional Vitamin D Deficiency?

Abstract: (The clinical trial registration number for this study is NCT00490412 and is available online at http://clinicaltrials.gov/ct2/show/ NCT00490412.)

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

1
67
1
2

Year Published

2014
2014
2024
2024

Publication Types

Select...
5
2
1

Relationship

0
8

Authors

Journals

citations
Cited by 59 publications
(71 citation statements)
references
References 48 publications
1
67
1
2
Order By: Relevance
“…In fact, bio-available vitamin D is sufficient, despite low total 25(OH) vitamin D levels, in subjects with low levels of VDBP (e.g., patients with liver cirrhosis) [9,10]. Conversely, an increase in serum VDBP may cause a functional vitamin D deficiency even in the presence of normal 25(OH) vitamin D values [14]. As a matter of fact, the potential benefit of measuring bio-available vitamin D concentrations, especially in the presence of abnormalities of VDBP, has been suggested [9,10].…”
mentioning
confidence: 99%
“…In fact, bio-available vitamin D is sufficient, despite low total 25(OH) vitamin D levels, in subjects with low levels of VDBP (e.g., patients with liver cirrhosis) [9,10]. Conversely, an increase in serum VDBP may cause a functional vitamin D deficiency even in the presence of normal 25(OH) vitamin D values [14]. As a matter of fact, the potential benefit of measuring bio-available vitamin D concentrations, especially in the presence of abnormalities of VDBP, has been suggested [9,10].…”
mentioning
confidence: 99%
“…O TDF, por exemplo, pode proporcionar uma redução na disponibilidade sanguínea de 1,25-dihidroxivitamina D livre e um aumento na concentração sérica de paratormônio a ponto de reduzir em até 7% a densidade mineral óssea 13 . Alguns estudos mostram, inclusive, que a suplementação de vitamina D3 em usuários de TDF pode reduzir os níveis sanguíneos de paratormônio, independentemente da concentração de vitamina D no sangue, beneficiando a pessoa contra a osteopenia 4,[12][13][14] .…”
Section: Dezembro De 2014unclassified
“…Alguns estudos mostram, inclusive, que a suplementação de vitamina D3 em usuários de TDF pode reduzir os níveis sanguíneos de paratormônio, independentemente da concentração de vitamina D no sangue, beneficiando a pessoa contra a osteopenia 4,[12][13][14] .…”
Section: Dezembro De 2014unclassified
“…Ultrasonogram of abdomen was done at the initiation of treatment. 6 and 12 months and in case of any specific reason/need in between.…”
Section: Methodsmentioning
confidence: 99%
“…5 The most common ADR of TDF are gastrointestinal complaints, headache and asthenia. Tenofovir-associated proximal renal tubulopathy causes excessive renal phosphate and calcium losses and 1-hydroxylation defects of vitamin D. 6 Signs of proximal renal tubular dysfunction include proteinuria, glucosuria, hypophosphatemia, hypouricemia, hypokalemia, low serum bicarbonate and/or elevated serum creatinine. 7 Tenofovir use has been associated with reduced bone mineral density and increases in biomarkers associated with bone metabolism, which may lead to an increase in fracture risk.…”
Section: Introductionmentioning
confidence: 99%